Publications en collaboration avec des chercheurs de Hacettepe University (1)

2022

  1. Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO)

    Lung Cancer, Vol. 166, pp. 107-113